Zobrazeno 1 - 10
of 542
pro vyhledávání: '"Arduino A. Mangoni"'
Autor:
Yogesh Sharma, Subodha Sumanadasa, Rashmi Shahi, Richard Woodman, Arduino A. Mangoni, Shailesh Bihari, Campbell Thompson
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Community-acquired pneumonia (CAP) poses a significant global health challenge, prompting exploration of innovative treatments. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of vitamin C supplementation i
Externí odkaz:
https://doaj.org/article/53db59915f4d4a899b97c854cc3d5b09
Autor:
Angelo Zinellu, Arduino A. Mangoni
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e35953- (2024)
Aim: There is an ongoing search for novel biomarkers of diabetes. We conducted a systematic review and meta-analysis of the serum concentrations of ischemia-modified albumin (IMA), a candidate biomarker of oxidative stress, acidosis, and ischemia, in
Externí odkaz:
https://doaj.org/article/506b3e9f92034f5fa51b8393e17c8f6d
Autor:
Angelo Zinellu, Arduino A. Mangoni
Publikováno v:
Immunity, Inflammation and Disease, Vol 12, Iss 7, Pp n/a-n/a (2024)
Abstract Introduction There is good evidence that specific autoimmune rheumatic diseases (RDs), for example, rheumatoid arthritis and systemic lupus erythematosus (SLE), are associated with a state of hypercoagulability and an increased risk of venou
Externí odkaz:
https://doaj.org/article/b5a18e0d228e4c2db69c9914ea2058f5
Autor:
Arduino A. Mangoni, Angelo Zinellu
Publikováno v:
Immunity, Inflammation and Disease, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract Introduction The identification of novel, easily measurable disease biomarkers might enhance the diagnosis and management of patients with rheumatic diseases (RDs). We conducted a systematic review and meta‐analysis of ischemia‐modified
Externí odkaz:
https://doaj.org/article/e86048e405ca416b917f18def9dae506
Autor:
Angelo Zinellu, Arduino A. Mangoni
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The identification of novel, yet easily measurable biomarkers of inflammation and oxidative stress might assist in the diagnosis and management of patients with rheumatic diseases (RDs). We conducted a systematic review and meta-analysis of studies i
Externí odkaz:
https://doaj.org/article/248e8b0f0c39460bbd3c8cc47c58a4b1
Autor:
Angelo Zinellu, Arduino A. Mangoni
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe identification of new, easily measurable biomarkers might assist clinicians in diagnosing and managing systemic sclerosis (SSc). Although the full blood count is routinely assessed in the evaluation of SSc, the diagnostic utility of s
Externí odkaz:
https://doaj.org/article/4202306afb024699b67b76c4c485e4b0
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27292- (2024)
Alterations of nitric oxide (NO) homeostasis have been described in mood disorders. However, the analytical challenges associated with the direct measurement of NO have prompted the search for alternative biomarkers of NO synthesis. We investigated t
Externí odkaz:
https://doaj.org/article/0997747290784ab69f0e44f3ced1bb91
Autor:
Jin Nuo Joan Tsang, Stephen Bacchi, Joshua G. Kovoor, Aashray K. Gupta, Brandon Stretton, Samuel Gluck, Toby Gilbert, Yogesh Sharma, Richard Woodman, Arduino A. Mangoni
Publikováno v:
The Journal of Clinical Hypertension, Vol 25, Iss 11, Pp 1036-1039 (2023)
Abstract The epidemiology of elevations in blood pressure is incompletely characterized, particularly in Australia. Given the lack of evidence regarding the frequency and the optimal management of in‐hospital hypertension, the authors performed a m
Externí odkaz:
https://doaj.org/article/294a74dd31c842b2b04abaa52327186c
Autor:
Arduino A. Mangoni, Salvatore Sotgia, Angelo Zinellu, Ciriaco Carru, Gianfranco Pintus, Giovanni Damiani, Gian Luca Erre, Sara Tommasi
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, Vol 17 (2023)
New evidence continues to accumulate regarding a significant association between excessive inflammation and dysregulated immunity (local and systemic) and the risk of cardiovascular events in different patient cohorts. Whilst research has sought to i
Externí odkaz:
https://doaj.org/article/ed8d7d4d30d747628dd8e4a82f9fe992
Autor:
Vinitha N. Ragavan, Pramod C. Nair, Natalia Jarzebska, Ramcharan Singh Angom, Luana Ruta, Elisa Bianconi, Silvia Grottelli, Natalia D. Tararova, Daniel Ryazanskiy, Steven R. Lentz, Sara Tommasi, Jens Martens-Lobenhoffer, Toshiko Suzuki-Yamamoto, Masumi Kimoto, Elena Rubets, Sarah Chau, Yingjie Chen, Xinli Hu, Nadine Bernhardt, Peter M. Spieth, Norbert Weiss, Stefan R. Bornstein, Debabrata Mukhopadhyay, Stefanie M. Bode-Böger, Renke Maas, Ying Wang, Antonio Macchiarulo, Arduino A. Mangoni, Barbara Cellini, Roman N. Rodionov
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) protects against cardiovascular disease by metabolising the risk factor asymmetric dimethylarginine (ADMA). However, the question whether the second DDAH isoform, DDAH2, directly metabolises
Externí odkaz:
https://doaj.org/article/c46891e5d10241cf95a530af2ca4d6b5